Sartorius Stedim Biotech S.A. (SSB) (Paris:DIM), a leading global supplier for the pharmaceutical and biotech industries, took out a long-term syndicated loan of 250 million euros for the next five years. The company signed the loan agreement with an international bank syndicate led by Commerzbank AG and Nord/LB. In addition, syndicate participants include BNP Paribas, […]

Cambridge, UK – Eagle Genomics (Eagle), an expert provider of bioinformatics software and services across a wide range of the life science and other sectors, has today announced the first closing of £590,000, as part of a planned £1million investment round in line with plans to expand its offerings. This first closing of the investment […]

Desktop Genetics Ltd (DeskGen), a UK bioinformatics company aiming to revolutionize the way genetic engineers work together, announced today that it has secured an equity investment of £275,000. The investment comes from Boundary Capital Ltd, Execute Technologies Inc, and angel investors Richard Youngman, Michael Martin (both of Anvil Partners LLP), Dr Jonathan Milner (CEO, AbCam […]

FREMONT, Calif., — WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today that it has commenced a private placement to accredited investors of up to $17.25 million of units consisting of shares of common stock, shares of Series 1 convertible preferred stock and warrants to purchase shares of common stock. At the initial closing of the offering […]

TORONTO — SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter-ended June 30, 2013. Highlights of Commercial Progress During the quarter the company executed two master services agreements with two […]

MINNEAPOLIS — MOCON, Inc. (Nasdaq: MOCO ) announced today that on August 21, 2013, its Board of Directors declared a quarterly cash dividend of eleven cents ($0.11) per share, payable on November 15, 2013, to shareholders of record on November 1, 2013. The Company has provided stockholders with quarterly dividends for the 101st consecutive quarter. […]

SAN DIEGO, Aug. — Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the three months and the six months ended June 30, 2013. Second Quarter 2013 Financial Results For the three months ended June 30, 2013, Trovagene reported a net loss of $5.3 million, or $0.34 per […]

RESEARCH TRIANGLE PARK, N.C. –As part of a new award from the National Human Genome Research Institute, RTI International will expand the PhenX Toolkit, a web-based resource that supports collaborative genomics and biomedical research. Use of PhenX measures will help researchers understand the relationships between genetics, health, disease and environment. The goals of the four-year, […]

WALTHAM, Mass.– The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on July 26, 2013. This dividend is payable on November 8, 2013, to all shareholders of record at the close of business on October 18, 2013. About PerkinElmer PerkinElmer, Inc. is a […]

TORONTO, CANADA – Jaguar Financial Corporation (“Jaguar”) (TSX: JFC) today announced, with the support of Cinnamon Investments Limited (“Cinnamon”), its proposed all-cash offer (“Offer”) to acquire all of the outstanding shares of Galvanic Applied Sciences Inc. (“Galvanic”) at a price of $2.00 per share. The Offer will be financed through a credit facility provided by […]